Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin and Forecast, 2015 – 2021

By Joel John Medical Devices

Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global endocrine testing market was valued at around USD 7.00 billion in 2015 and is expected to reach approximately USD 10.50 billion by 2021, growing at a CAGR of around 8.5% between 2016 and 2021.The endocrine system is a family of glands and organs in the human body. The endocrine system consists of various glands in different parts of the body that secrete hormones directly into the blood. An optimally functioning endocrine system is essential to restoring and maintaining good health. Endocrinology blood tests to identify hormone imbalances and abnormal gland function.

[wptab name=’Report Description’ active=”1″ ]

Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global endocrine testing market was valued at around USD 7.00 billion in 2015 and is expected to reach approximately USD 10.50 billion by 2021, growing at a CAGR of around 8.5% between 2016 and 2021.

The endocrine system is a very complex network that consists of several glands located throughout the body. Endocrine diagnostics test to measure the level of various hormones in a human body. It is also used to identify whether the endocrine glands are working properly. An optimally functioning endocrine system is essential to restoring and maintaining health.

Globally, the endocrine testing market has been accelerated on account of the rapid growth global geriatric population in both developed and developing countries. The changing lifestyles, increasing stress, and unhealthy food habits result in increased obesity and disturbed hormonal changes, which contributed substantially towards the growth of the endocrine diagnostics market. Moreover, increasing health awareness coupled with the government initiatives facilitated early diagnosis of endocrine disorders, which is expected to propel the demand for endocrine test kits. However, the high cost of technology is expected to be the major restraint for the growth of the endocrine testing market. Nonetheless, investment in research and technology is considered as a major opportunity for the growth of the global endocrine testing market.

Global Endocrine Testing Market

The endocrine testing market can be segmented on the basis of test such as Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests such as gastrin, thymosin, and secretin tests. Thyroid stimulating hormone (TSH) was the leading segment owing to rising incidences of thyroid disorders and the growing awareness about the correlation between variations in the thyroid hormones levels and cardiovascular disorders. Insulin test is expected to witness the fastest growth in the years to come. This growth is mainly due to increase the rate of diabetes patients across the globe.

On the basis of technology, the market can be segmented into monoclonal & polyclonal antibody technologies, tandem mass spectrometry, immunoassay, sensors, clinical chemistry technologies, and others. Tandem mass spectrometry is expected to show significant growth in the years to come. Mass spectroscopy analysis is the most recent developed technology. The sensitivity of the tests by mass spectroscopy technology is very high.

Some of the key end-users include commercial laboratories, home-based tests, ambulatory care centers, hospitals and other healthcare settings. The commercial laboratories were the largest segment due to advanced infrastructure coupled with skilled personnel. The home-based test segment is growing fast with the introduction of new user-friendly and cost-effective diagnostic kits. This is expected to increase the penetration of home-based tests.

North America is projected to be the largest revenue contributing region. North America is expected to remain the dominant region over the next few years. Asia-Pacific is projected to be the fastest-growing region in the endocrine testing market during the forecast period as a result of demand from developing economies such as China and India. As a result of increasing aging population and increasing health awareness in Brazil, Latin America is also expected to experience significant growth in the years to come.

Some of the key players operating into this market include Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies and bioMerieux SA.

[/wptab]
[wptab name=’Table of content’]

  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Endocrine Testing Market, 2015 – 2021 (USD Million)
    • 2.2. Global Endocrine Testing Market: Snapshot
  • Chapter 3. Endocrine Testing – Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Endocrine testing Market Drivers: Impact Analysis
      • 3.2.2. Rising Diabetic and Obese Population
    • 3.3. Market Restraints
      • 3.3.1. Global Endocrine testing Market Restraints: Impact Analysis
      • 3.3.2. High Cost of Technology
    • 3.4. Opportunities
      • 3.4.1. Innovative Products
    • 3.5. Porter’s Five Forces Analysis
      • 3.5.1. Bargaining Power Of Suppliers
      • 3.5.2. Bargaining Power Of Buyers
      • 3.5.3. Threat From New Entrants
      • 3.5.4. Threat From New Substitutes
      • 3.5.5. Degree Of Competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market Attractiveness Analysis, By Test Segment
      • 3.6.2. Market Attractiveness Analysis, By Technology Segment
      • 3.6.3. Market Attractiveness Analysis, By End-User Segment
      • 3.6.4. Market Attractiveness Analysis, By Regional Segment
  • Chapter 4. Global Endocrine Testing Market – Competitive Landscape
    • 4.1. Company Market Share, 2015 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
      • 4.2.4. Research And Development, Regional Expansion
    • 4.3. Type Portfolio
  • Chapter 5. Global Endocrine Testing Market – Test Analysis
    • 5.1. Global Endocrine Testing Market: Test Segment Overview
      • 5.1.1. Global Endocrine Testing Market Revenue Share, By Test, 2015 And 2021
    • 5.2. Dehydroepiandrosterone Sulfate
      • 5.2.1. Global Endocrine Testing Market for Dehydroepiandrosterone Sulfate, 2015 – 2021 (USD Million)
    • 5.3. Progesterone
      • 5.3.1. Global Endocrine Testing Market for Progesterone, 2015 – 2021 (USD Million)
    • 5.4. Luteinizing Hormone
      • 5.4.1. Global Endocrine Testing Market For Luteinizing Hormone, 2015 – 2021 (USD Million)
    • 5.5. Estradiol
      • 5.5.1. Global Endocrine Testing Market for Estradiol, 2015 – 2021 (USD Million)
    • 5.6. Human Chorionic Gonadotropin
      • 5.6.1. Global Endocrine Testing Market for Human Chorionic Gonadotropin, 2015 – 2021 (USD Million)
    • 5.7. Follicle Stimulating
      • 5.7.1. Global Endocrine Testing Market for Follicle Stimulating, 2015 – 2021 (USD Million)
    • 5.8. Testosterone
      • 5.8.1. Global Endocrine Testing Market for Testosterone, 2015 – 2021 (USD Million)
    • 5.9. Thyroid Prolactin
      • 5.9.1. Global Endocrine Testing Market for Thyroid Prolactin, 2015 – 2021 (USD Million)
    • 5.10. Thyroid Stimulating Hormone
      • 5.10.1. Global Endocrine Testing Market for Thyroid Stimulating Hormone, 2015 – 2021 (USD Million)
    • 5.11. Cortisol
      • 5.11.1. Global Endocrine Testing Market for Cortisol, 2015 – 2021 (USD Million)
    • 5.12. Insulin
      • 5.12.1. Global Endocrine Testing Market for Insulin, 2015 – 2021 (USD Million)
    • 5.13. Others
      • 5.13.1. Global Endocrine Testing Market for Other Test, 2015 – 2021 (USD Million)
  • Chapter 6. Global Endocrine Testing Market – Technology Segment Analysis
    • 6.1. Global Endocrine testing Market: Technology Segment Overview
      • 6.1.1. Global Endocrine testing Market Revenue Share, By Technology, 2015 And 2021
    • 6.2. Monoclonal & Polyclonal Antibody Technologies
      • 6.2.1. Global Endocrine Testing Market For Monoclonal & Polyclonal Antibody Technologies, 2015 – 2021 (USD Million)
    • 6.3. Tandem Mass Spectrometry
      • 6.3.1. Global Endocrine Testing Market For Tandem Mass Spectrometry, 2015 – 2021 (USD Million)
    • 6.4. Immunoassay
      • 6.4.1. Global Endocrine Testing Market for Immunoassay, 2015 – 2021 (USD Million)
    • 6.5. Clinical Chemistry Technologies
      • 6.5.1. Global Endocrine Testing Market for Clinical Chemistry Technologies, 2015 – 2021 (USD Million)
    • 6.6. Other
      • 6.6.1. Global Endocrine Testing Market for Other Technologies, 2015 – 2021 (USD Million)
  • Chapter 7. Global Endocrine Testing Market – End-User Segment Analysis
    • 7.1. Global Endocrine testing Market: End-User Segment Overview
      • 7.1.1. Global Endocrine testing Market Revenue Share, By End-User, 2015 And 2021
    • 7.2. Commercial Laboratories
      • 7.2.1. Global Endocrine Testing Market For Commercial Laboratories, 2015 – 2021 (USD Million)
    • 7.3. Home-Based Tests
      • 7.3.1. Global Endocrine Testing Market for Home-Based Tests 2015 – 2021 (USD Million)
    • 7.4. Ambulatory Care Centers
      • 7.4.1. Global Endocrine Testing Market for Ambulatory Care Centers 2015 – 2021 (USD Million)
    • 7.5. Hospitals
      • 7.5.1. Global Endocrine Testing Market for Hospitals 2015 – 2021 (USD Million)
    • 7.6. Other
      • 7.6.1. Global Endocrine Testing Market for other, 2015 – 2021 (USD Million)
  • Chapter 8. Global Endocrine Testing Market – Regional Segment Analysis
    • 8.1. Global Endocrine Testing Market: Regional Overview
      • 8.1.1. Global Endocrine Testing Market Revenue Share, By Region, 2015 And 2021
    • 8.2. North America
      • 8.2.1. North America Endocrine Testing Market Revenue, By Test, 2015 – 2021 , (Usd Million)
      • 8.2.2. North America Endocrine Testing Market Revenue, By Technology, 2015 – 2021 , (USD Million)
      • 8.2.3. North America Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 , (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Endocrine Testing Market Revenue, By Test, 2015 – 2021 (USD Million)
      • 8.3.2. Europe Endocrine Testing Market Revenue, By Technology, 2015 – 2021 (USD Million)
      • 8.3.3. Europe Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Endocrine Testing Market Revenue, By Test, 2015 – 2021 (USD Million)
      • 8.4.2. Asia Pacific Endocrine Testing Market Revenue, By Technology, 2015 – 2021 (USD Million)
      • 8.4.3. Asia Pacific Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Endocrine Testing Market Revenue, By Test, 2015 – 2021 (USD Million)
      • 8.5.2. Latin America Endocrine Testing Market Revenue, By Technology, 2015 – 2021 (USD Million)
      • 8.5.3. Latin America Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 (USD Million)
    • 8.6. Middle East And Africa
      • 8.6.1. Middle East And Africa Endocrine Testing Market Revenue, By Test, 2015 – 2021 (USD Million)
      • 8.6.2. Middle East And Africa Endocrine Testing Market Revenue, By Technology, 2015 – 2021 (USD Million)
      • 8.6.3. Middle East And Africa Endocrine Testing Market Revenue, By End-User Type, 2015 – 2021 (USD Million)
  • Chapter 9. Company Profile
    • 9.1. Abbott Laboratories
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. AB Sciex Pte.Ltd.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Agilent Technologies
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Biomedical Technologies.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. bioMerieux SA
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Bio-Rad Laboratories.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. DiaSorin S.p.A.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Hoffmann-La Roche Ltd.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Quest Technology
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Thermo Fisher Scientific, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global Endocrine Testing  Market Revenue, 2015 – 2021 (USD Million)
4. Porter’s Five Forces Analysis
5. Endocrine Testing: Market Attractiveness Analysis, By Test Segment
6. Endocrine Testing: Market Attractiveness Analysis, By Technology Segment
7. Endocrine Testing: Market Attractiveness Analysis, By  End-User Segment
8. Endocrine Testing: Market Attractiveness Analysis, By Regional Segment
9. Company Market Share Analysis, 2015 And 2021
10. Global Endocrine testing Market Revenue Share By Test, 2015 And 2021
11. Global Endocrine testing Market for Dehydroepiandrosterone Sulfate, 2015 – 2021, (USD Million)
12. Global Endocrine testing Market for Luteinizing Hormone, 2015 – 2021, (USD Million)
13. Global Endocrine testing Market for Human Chorionic Gonadotropin, 2015 – 2021, (USD Million)
14. Global Endocrine testing Market for Follicle Stimulating, 2015 – 2021, (USD Million)
15. Global Endocrine testing Market for Thyroid Stimulating Hormone, 2015 – 2021, (USD Million)
16. Global Endocrine testing Market for Insulin, 2015 – 2021, (USD Million)
17. Global Endocrine Testing Market For Cortisol, 2015 – 2021, (USD Million)
18. Global Endocrine Testing Market For Other Test, 2015 – 2021, (USD Million)
19. Global Endocrine Testing Market Revenue Share By Technology, 2015 And 2021
20. Endocrine Testing Market For Monoclonal & Polyclonal Antibody Technologies, 2015 – 2021, (USD Million)
21. Endocrine Testing Market For Tandem Mass Spectrometry, 2015 – 2021, (USD Million)
22. Endocrine Testing Market For Clinical Chemistry Technologies, 2015 – 2021, (USD Million)
23. Global Endocrine Testing Market Revenue Share By End-User, 2015 And 2021
24. Endocrine Testing Market For Hospitals, 2015 – 2021, (USD Million)
25. Endocrine Testing Market For Others, 2015 – 2021, (USD Million)
26. Global Endocrine Testing Market Share, By Region, 2015 – 2021

List of Tables

1. Endocrine testing Market: Market Snapshot
2. Drivers Of Global Endocrine testing Market: Impact Analysis
3. Restraints Of Global Endocrine testing Market: Impact Analysis
4. North America Endocrine Testing Market Revenue, By Test, 2015 – 2021(USD Million)
5. North America Endocrine Testing Market Revenue, By Technology, 2015 – 2021(USD Million)
6. North America Endocrine Testing Market Revenue, By End-User, 2015 – 2021(USD Million)
7. Europe Endocrine Testing Market Revenue, By Test, 2015 – 2021(USD Million)
8. Europe Endocrine Testing Market Revenue, By Technology, 2015 – 2021(USD Million)
9. Europe Endocrine Testing Market Revenue, By End-User, 2015 – 2021(USD Million)
10. Asia Pacific Endocrine Testing Market Revenue, By Test 2015 – 2021(USD Million)
11. Asia Pacific Endocrine Testing Market Revenue, By Technology 2015 – 2021(USD Million)
12. Asia Pacific Endocrine Testing Market Revenue, By End-User 2015 – 2021(USD Million)
13. Latin America Endocrine Testing Market Revenue, By Test – 2021 (USD Million)
14. Latin America Endocrine Testing Market Revenue, By Technology – 2021 (USD Million)
15. Latin America Endocrine Testing Market Revenue, By End-User – 2021 (USD Million)
16. Middle East And Africa Endocrine Testing Market Revenue, By Test – 2021 (USD Million)
17. Middle East And Africa Endocrine Testing Market Revenue, By Technology – 2021 (USD Million)
18. Middle East And Africa Endocrine Testing Market Revenue, By End-User – 2021 (USD Million)

[/wptab]
[wptab name=’Request For Sample’]

    * Indicates required field.

    Your Name*

    Your Email*

    Telephone Number*

    Name of company*

    Country Name*

    How can we help you?

    Prove You are Human*

    captcha
    Enter Capcha Image Properly

    [simplehidden rpt_title]
    [simplehidden ip_add]
    [simplehidden src_url]

    [/wptab]

    [end_wptabset]